Conference highlights
Joint leadership roundtables
India’s Visionary Leaders Panel: Propelling India’s growing pharmaceutical industry through innovations and strategic partnerships
India is gaining momentum in positioning itself as significant player in the global biopharmaceutical industry. India’s leading pharmaceutical companies are making their mark in the local and international markets by producing high quality and reliable drugs. On top of this, these top players are still finding various ways to expand their businesses. They aim to form strategic partnerships, drive innovation and venture into new markets. What are the key drivers and future opportunities for India’s biopharmaceutical players within India and internationally? How can India successfully leverage on its growing biopharmaceutical industry?
Global Visionary Leaders Panel: Driving the biopharmaceutical industry growth by developing effective and successful business models in emerging markets
Emerging markets will be the future growth drivers of the biopharmaceutical industry. With the rising affluence of these markets, global pharmas are setting their sights to high growth and promising countries. Asia is one of the top regions that present great market potential. With high quality talent pool, developing infrastructure and growing population, it is a strategic location for global pharmas. India has been identified as an ideal location in Asia. How can global pharmas leverage on India’s burgeoning biopharmaceutical industry? What are the necessary action plans to fully tap Asia’s emerging markets?
Head of clinical trials development symposium
Clinical heads from Indian and global pharmas will come together to share the latest clinical trials projects, best practices and outsourcing models. These decision makers will share their perspectives on the outlook of India’s clinical trials industry.
Global regulator roundtable
Regulators and regulation experts from key markets of Europe, USA, Asia and India will update on their latest guidelines of clinical practices, requirement for data quality, and approval processes.
Successful partnerships and outsourcing models session
Global pharma and biotech are looking at emerging markets to expand their clinical trials either through offshoring or outsourcing. India presents itself as an attractive destination for cost effective and efficient clinical studies. Find out the various successful partnership models between global and local players for clinical trials.
Global and Indian leading CRO parade
With global pharmas shifting their clinical trial activities to India, more and more CROs have emerged in India to cater to this growing demand. To look for the most suitable partner for your drug development activities in India, do not miss our CRO parade where we showcase the clinical service capabilities of top leading CROs in India
Biosimilar focused session
EU and US markets are opening their doors to biosimilars. With these developments, global players and Indian players are setting their sights in entering the biosimilars market. This focused session will discuss the challenges and difficulties in biosimilars’ clinical trials for EU/US approval.
Best clinical supply methodologies review
Pharmas and biotechs in India face severe logistics and supply chain challenges due to appalling infrastructure, culture differences and etc. In this session, pharmas, biotechs and clinical supply chain solution providers will share best practices in expediting clinical trials processes in India.
Best clinical sites showcase
Quality sites that fulfilled regulatory requirements are diffi cult to find in India. At this event, leading clinical sites across India will gather to showcase their capabilities and facilities. This will be an ultimate platform for pharmas and biotechs to evaluate and choose the best clinical sites, at one venue, for their future clinical trials.
©Terrapinn Holdings Ltd. MMX